Safety of viral DNA in biological products

Biologicals

Volumn 26, Issue 4, 1998, Pages 317-320

  Krause, Philip R ^a   Lewis Jr , Andrew M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; CELL DNA; IMMUNOGLOBULIN; VIRUS DNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG CONTAMINATION; DRUG SAFETY; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS INFECTIVITY;

EID: 0032467449     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1998.0161     Document Type: Article

References (11)

1. 1. Temin HM. Overview of biologic effects of addition of DNA molecules to cells. J Med Viron 1990; 31: 13-17.
2. 2. Kurth R. Risk potential of the chromosomal insertion of foreign DNA. Ann NY Acad Sci 1995; 772: 140-151.
3. 3. Verma IM, Somia N. Gene therapy-promises, problems and prospects. Nature 1997; 389: 239.
4. 4. Center for Biologics Evaluation and Research. Points to Consider on Plasmid DNA Vaccines for Prevention of Infectious Diseases, August 1996.
5. 5. WHO Technical Report Series 747. Acceptability of cell substrates for production of Biologicals. World Health Organization, Geneva, 1987.
6. 6. Petricciani JC, Horaud FN. DNA, dragons and sanity. Biologicals 1995; 23: 233-238.
7. 7. Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465-1468.
8. 8. Letvin NL, Lord CI, King NW et al. Risks of handling HIV. Nature 1991; 349: 573.
9. + T Cells. J AIDS 1993; 6: 237-240.
10. 10. Schwarz E, Freese UK, Gissman L et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985; 314: 111-114.
11. 11. Bartal AH, Feit C, Erlandson R et al. The presence of viral particles in hybridoma clones secreting monoclonal antibodies. N Engl J Med 1982; 306: 1423.